FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Glenmark Pharmaceuticals Indomethacin Capsules Recall

Indomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark…

Glenmark Pharmaceuticals Inc., USA · Mahwah, NJ

Risk level
Class III
Reported by FDA
Apr 4, 2018
Recall ID
D-0606-2018
Check your lot numberHow we source this data

Summary

Glenmark Pharmaceuticals recalled Indomethacin Capsules starting Mar 19, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0606-2018 on Apr 4, 2018. Reason: Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual adult dosage of "One capsule 2 or 3 times a day. Status: Terminated.

Why it was recalled

Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual adult dosage of "One capsule 2 or 3 times a day.

Product description

Indomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-302-01.

Lot numbers, UPCs & expiration codes

Lot #: 19172776, 19172794, Exp 07/19; 19173111, 19173186, 19173188, 19173189, Exp 08/19; 19173852, 19173878, 19173893, Exp 10/19; 19174318, 19174341, Exp 11/19.

Where it was sold

Nationwide in the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0606-2018
Classification
Class III
Status
Terminated
Recall initiated
Mar 19, 2018
FDA report date
Apr 4, 2018
Quantity
109,080 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Glenmark Pharmaceuticals Inc., USA

Original FDA data

Every field from FDA enforcement report D-0606-2018, exactly as published.

Show all FDA fields
City
Mahwah
State
NJ
Status
Terminated
Country
United States
Event ID
79570
Address
750 Corporate Dr
Code information
Lot #: 19172776, 19172794, Exp 07/19; 19173111, 19173186, 19173188, 19173189, Exp 08/19; 19173852, 19173878, 19173893, Exp 10/19; 19174318, 19174341, Exp 11/19.
Postal code
07430-2009
Report date
Apr 4, 2018
Product type
Drugs
Recall number
D-0606-2018
Classification
Class III
Recalling firm
Glenmark Pharmaceuticals Inc., USA
Product quantity
109,080 Bottles
Termination date
Dec 16, 2019
Reason for recall
Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual adult dosage of "One capsule 2 or 3 times a day.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Indomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-302-01.
Distribution pattern
Nationwide in the United States.
Recall initiation date
Mar 19, 2018
Initial firm notification
Letter
Center classification date
Mar 26, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0606-2018, published Apr 4, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls